View Post

England Offers Ample Access to UTI Vaccines

In COVID-19, Latest News by Precision Vaccinations

The United Kingdom's NHS recently updated its urinary tract infection (UTI) webpage to explain that some people may experience persistent UTI symptoms, and current urine tests may not detect chronic infections caused by bacteria embedded in the bladder lining.
Chronic UTIs, also known as recurrent UTIs (rUTIs), are typically treated with antibiotics. The NHS advises patients to ask their GP to refer them to a specialist if they experience rUTIs.

View Post

Which Vaccines Are Recommend for France's Summer Olympics

In COVID-19, Latest News by Precision Vaccinations

As we approach the Paris 2024 Olympic and Paralympic Games in late July and August, a recent study has looked into the possibility of using wastewater surveillance to detect priority pathogens that can be monitored during these events.
On July 11, 2024, the researchers published a list of 60 important pathogens in Eurosurveillance to be monitored for public health during the 2024 Games.

View Post

Second-Gen Passive Immunization Significantly Protects Infants from RSV

In COVID-19, Latest News by Precision Vaccinations

The New England Journal of Medicine recently published the results of a randomized controlled clinical trial that reaffirms the estimated effectiveness of Beyfortus™ (nirsevimab), a second-generation monoclonal antibody that reduces the risk of hospitalization for respiratory syncytial virus (RSV)- associated bronchiolitis in infants by 83%.
This finding is significant since RSV is the leading cause of bronchiolitis, resulting in about three million hospitalizations each year worldwide.

View Post

Brazil Considers Recombinant BCG Vaccine for Infants

In COVID-19, Latest News by Precision Vaccinations

While most infants in Brazil's five regions are vaccinated against tuberculosis, the search for a more effective Bacillus Calmette-Guérin (BCG) vaccine accelerated in 2024. 
Researchers from the Butantan Institute and collaborators confirmed on July 3, 2024, that they are developing a more potent version of the 100-year-old BCG vaccine.

View Post

Portfolio of Influenza Vaccines Shipped Ahead of 2024-2025 Flu Season

In COVID-19, Latest News by Precision Vaccinations

According to Stefan Merlo, Vice President of Commercial Operations, North America, CSL Seqirus, pharmacies in the United States will soon offer updated flu shots.
Mr. Merlo exclusively informed Precision Vaccinations News that as of July 9, 2024, CSL Seqirus was already shipping its differentiated influenza vaccines for the 2024/25 Northern Hemisphere flu season.
"This year, we've transitioned to trivalent vaccine formulations, aligning with U.S. FDA guidelines."

View Post

Some Seniors Get HPV Too

In COVID-19, Latest News by Precision Vaccinations

According to a new study from FAIR Health, those aged 65 and older were the group with the most significant increase (23.8%) in sexually transmitted disease (STD) diagnoses from 2020-2023.
Among the other FAIR Health findings, people 65 and older had the most significant increase (32.2%) in human papillomavirus (HPV) diagnoses.
Furthermore, 21.9% of HPV cases occurred among patients aged 55 to 64.
However, Fair Health's data did not disclose if these HPV cases were in adults who had been vaccinated, when they were vaccinated, or were unvaccinated.

View Post

Vaccination Can Reduce Gonorrhea Cases

In COVID-19, Latest News by Precision Vaccinations

The Journal of Infection recently published insights on how vaccination can reduce the incidence of gonorrhea, a common sexually transmitted disease. Gonorrhea is one of the fastest-growing diagnoses by percent change (16.8%).
This new study's findings indicate that MenB vaccines may offer moderate protection against gonococcal infections.

View Post

Zika, Dengue, Chikungunya Co-Infections Reported

In COVID-19, Latest News by Precision Vaccinations

At least two Zika patients have reported co-infection of chikungunya and dengue in Pune, India. The Times of India reported on July 5, 2024, that an official from the National Institute of Virology (NIV) told the media that Pune City is a hotspot for vector-borne diseases.
Therefore, co-infections with chikungunya and dengue are not entirely out of the blue. However, their severity can be debatable, says the NIV.